Search Within

Francis M Sirotnak

Formats
  1. Journal Article (132)
  2. Meeting Abstract (49)
  3. Conference Paper (3)
Groups
  1. Department of Medicine (48)
  2. Solid Tumor Oncology Division (34)
  3. Thoracic Oncology (27)
  4. Genitourinary Oncology Service (18)
  5. Sloan Kettering Institute Faculty (16)
  6. Center for Hematologic Malignancies (15)

More Groups

People
  1. Mark Kris (27)
  2. Krishnendu Roy (20)
  3. Yuhong She (19)
  4. Vincent Miller (18)
  5. Glenys Otter (17)
  6. Howard Scher (16)

More People

Years
  1. 2017 (1)
  2. 2011 (1)
  3. 2009 (3)
  4. 2008 (1)
  5. 2007 (4)
  6. 2006 (3)

More Years

Publications
  1. Proceedings of the American Association for Cancer Research Annual Meeting (28)
  2. Clinical Cancer Research (22)
  3. Journal of Biological Chemistry (18)
  4. Journal of Medicinal Chemistry (18)
  5. Cancer Research (16)
  6. Gene (9)

More Publications

Publishers
  1. American Association for Cancer Research (67)
  2. American Chemical Society (22)
  3. American Society for Biochemistry and Molecular Biology (18)
  4. Elsevier Science, Inc. (13)
  5. Elsevier Inc. (11)
  6. Springer (9)

More Publishers

Results (184)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Regulation of transcription of the human MRP7 gene. Characteristics of the basal promoter and identification of tumor-derived transcripts encoding additional 5′ end heterogeneity
    Journal Article

    Dabrowska, M.; Sirotnak, F. M.
    Gene (2004)

    Fulltext@MSK | Save
  • Pulsatile administration of the EGF receptor inhibitor Iressa (ZD1839) is significantly more effective than continuous dosing for sensitizing tumors to taxol
    Meeting Abstract

    Solit, D. B.; She, Y.; Moasser, M. M.; Hudis, C. A.; Kris, M. G.; Scher, H. I.; Rosen, N.; Sirotnak, F. M.
    Proceedings of the American Association for Cancer Research Annual Meeting (2003)

    Fulltext@MSK | Save
  • Transcriptional up-regulation of pre-m-RNA splicing factor Srp20: A novel mechanism of flavopiridol induced apoptosis in human colon cancer cells
    Meeting Abstract

    Motwani, M. V.; Cheema, H. S.; Sridhar, P.; Sirotnak, F. M.; Schwartz, G. K.
    Proceedings of the American Association for Cancer Research Annual Meeting (2003)

    Fulltext@MSK | Save
  • Design, synthesis, and SAR of 2nd generation actinonin analogs
    Meeting Abstract

    Borella, C. P.; Lee, M.; Ju, H.; She, Y.; Sirotnak, F.; Scheinberg, D. A.; Tong, W. P.; Bornmann, W. G.
    Proceedings of the American Association for Cancer Research Annual Meeting (2003)

    Fulltext@MSK | Save
  • Pulsatile administration of the EGF receptor inhibitor gefitinib (Iressa, ZD 1839) is significantly more effective than continuous dosing for sensitizing tumors to Taxol
    Meeting Abstract

    Solit, D. B.; She, Y.; Moasser, M.; Hudis, C.; Kris, M.; Scher, H.; Rosen, N.; Sirotnak, F. M.
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save
  • Design, synthesis and SAR of actinonin analogs
    Meeting Abstract

    Borella, C. P.; Bornmann, W. G.; Scheinberg, D. A.; Sirotnak, F.; Lee, M.
    Abstracts of Papers of the American Chemical Society (2003)

    Fulltext@MSK | Save
  • Phase 1 study of 10-propargyl-10-deazaaminopterin (PDX) plus docetaxel or paclitaxel in patients with advanced cancer
    Meeting Abstract

    Azzoli, C. G.; Krug, L. M.; Miller, V. A.; Sharma, S.; Gomez, J.; Kris, M. G.; Ginsberg, M.; Baez, V.; Henry, R.; Tyson, L.; more...
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save
  • Studies with ZD1839 in preclinical models
    Journal Article

    Sirotnak, F. M.
    Seminars in Oncology (2003)

    Fulltext@MSK | Save
  • Activity of a novel anti-folate (PDX, 10-propargyl 10-deazaaminopterin) against human lymphoma is superior to methotrexate and correlates with tumor RFC-1 gene expression
    Journal Article

    Wang, E. S.; O'connor, O.; She, Y.; Zelenetz, A. D.; Sirotnak, F. M.; Moore, M. A. S.
    Leukemia and Lymphoma (2003)

    Fulltext@MSK | Save
  • The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 selectively potentiates radiation response of human tumors in nude mice, with a marked improvement in therapeutic index
    Journal Article

    She, Y.; Lee, F.; Chen, J.; Haimovitz-Friedman, A.; Miller, V. A.; Rusch, V.; Kris, M. G.; Sirotnak, F. M.
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save